WhereScape Announces Cloud Data Warehouse Automation for Snowflake
WhereScape, the leading provider of data infrastructure automation software, today announced WhereScape® automation for Snowflake, an offering designed to help IT organizations speed up the delivery of cloud-based data infrastructure projects. WhereScape will showcase the new offering this week during the TDWI Conference in Anaheim, Calif.
WhereScape automation for Snowflake automates key development and operations workflows for Snowflake customers based on the native functions, wizards and best practices of Snowflake and incorporates data warehouse modelling methodologies such as 3NF, dimensional and Data Vault 2.0. Snowflake provides cloud-based data warehousing solutions that deliver the performance, elasticity, scalability, concurrency and simplicity needed to store and analyze all of an organization’s data in one location.
“The combination of WhereScape’s data warehouse automation tools with Snowflake's zero administration service is perfect for enabling our customers to be successful with agile data warehousing,” said Kent Granziano, senior technical evangelist of Snowflake. “WhereScape automation for Snowflake makes it possible for organizations to start using Snowflake faster and more easily by simplifying and automating the design, build and population of data warehouse tables. Our customers will benefit from the effortless, simple, drag and drop interface, with which they can point at a source database, or even flat files, then load that data right into Snowflake with zero coding! That is agile.”
“Our health and life sciences clients rely on us to execute flawless marketing campaigns and deliver customer insights from across our many digital platforms,” said Peter Nilsson, Chief Technology Officer of Aptus Health. “To that end, we’re leveraging WhereScape’s ability to ease our design and implementation effort as we develop our fully-integrated warehouse on Snowflake. WhereScape's tools will save us thousands of engineering hours, promote implementation accuracy, and accelerate our time to delivery. And since WhereScape natively supports Snowflake, we can use the generated code without having to tailor it to our target environment—letting us focus on generating the insights that will drive our business forward.”
WhereScape automation for Snowflake includes:
- WhereScape® 3D for Snowflake helping IT teams quickly and effectively tackle the upfront planning, modelling and design needed to rapidly put Snowflake to use. WhereScape 3D data discovery and profiling tools allow customers to more easily understand new data sources and leverage automation built for Snowflake to quickly build, test and iterate on prototypes with business users.
- WhereScape® RED for Snowflake, an integrated development environment, providing IT teams the ability to develop, deploy and operate Snowflake data infrastructure faster. With built-in automation based on native Snowflake functions, wizards and best practices, customers can eliminate the time-intensive hand-coding involved in data infrastructure development. Advanced DevOps capabilities allow users to quickly establish new environments, continuously migrate changes and operate data processing in Snowflake – all with best practices automatically utilized. WhereScape RED for Snowflake automatically generates and maintains user and technical documentation such as data lineage, track back, and track forward for future reference, lifting a time-intensive burden off IT teams.
- WhereScape® Data Vault Express™ for Snowflake, an integrated combination of WhereScape 3D and WhereScape RED embedded with Data Vault 2.0 specific capabilities, empowering teams to more practically deliver data vaults.
"Whether large or small, organizations today are grappling with the strategy, tactics and timing of moving on-premises data into the cloud," said Matt Aslett, Research Director of 451 Research. "Automating data movement and populating data warehouse tables in the cloud promises to smooth the transition path for IT teams, providing more time to focus on the business value of the transition and associated analytics applications.”
“IT faces enormous pressure to deliver decision-support information faster than ever before,” said Mark Budzinski, CEO of WhereScape. “As the growth of data doubles nearly every other year, organizations are increasingly feeling squeezed for resources and time. Many look to the cloud to address these challenges. We are excited to help Snowflake customers maximize their adoption of a cloud strategy and fast-track their use of Snowflake by addressing head-on the thrash and hidden costs of designing, developing, deploying and operating data infrastructure.”
Mark Budzinski, CEO of WhereScape, and Jon Bock, VP of product and partner marketing for Snowflake Computing, will discuss the offering together today on the #InsideAnalysis radio podcast at 3PM ET, with a follow-up Deep Dive Webcast at 4PM ET. Additionally, WhereScape’s Jason Laws, vice president of product management, will present today at the TDWI Leadership Summit at 2:15PM PT.
WhereScape helps IT organizations of all sizes leverage automation to design, develop, deploy, and operate data infrastructure faster. More than 700 customers worldwide rely on WhereScape automation to eliminate hand-coding and other repetitive, time-intensive aspects of data infrastructure projects to deliver data warehouses, vaults, lakes and marts in days or weeks rather than in months or years. WhereScape has offices in Portland, Oregon; Reading, UK; Auckland, New Zealand; and Singapore. For more information, please visit www.wherescape.com
All products or company names herein may be trademarks of their respective owners.
Ruth Armitage/Sarah Shkargi
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
AURAK Gains SACSCOC Accreditation15.12.2018 10:49 | Pressemelding
The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41 | Pressemelding
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42 | Pressemelding
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00 | Pressemelding
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07 | Pressemelding
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha